Where is Idea-Amd located?

Idea-Amd is headquartered in Germany.

Where does Idea-Amd rank among its competitors?

Idea-Amd ranks 9th amongst 9 active competitors, of which 3 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Science, which secured $230M in Feb, 2026.

Who are the top competitors of Idea-Amd?

Idea-Amd's top competitors include Science, Samsara Vision and Espansione Group. Among them, Science secured the most recent funding round in February, 2026.

Idea-Amd - 2026 Company Profile & Competitors

Idea-Amd is an unfunded company based in Germany. It operates as a Developer of diagnostic and assistive technology for macular degeneration patients. Idea-Amd has not raised any funding yet. The company has 9 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like Science, Samsara Vision and Espansione Group.

Company Details

Developer of diagnostic and assistive technology for macular degeneration patients. The technology aims to help individuals manage daily life and maintain independence. It focuses on clinical diagnostic systems using virtual reality. The systems support clinical tests and monitor disease progression through eye movement analysis. Assistive functions use augmented reality to aid in various daily situations. The technology also provides training in coping strategies.

Key Metrics

Location

Germany

Stage

Unfunded

Ranked

9^th among 9 active competitors

Similar Companies

Science & 7 more

View Idea-Amd's full profile

Idea-Amd has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Idea-Amd include Science, Samsara Vision and Espansione Group. Here is the list of Top 10 competitors of Idea-Amd, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Science 2021, Alameda (United States), Series C	Provider of online science magazine	$490M	Khosla Ventures, RAA Capital & 9 others	63/100
2nd	Samsara Vision 1997, Far Hills (United States), Series E	Provider of a specialty medical device company focusing on the development, manufacturing, and marketing of proprietary implantable ophthalmic devices designed to improve central vision for late-stage age-related macular degeneration (AMD) patients	$55M	Saints Capital, Boston Scientific & 9 others	50/100
3rd	Espansione Group 1981, Bologna (Italy), Acquired	Developer of Photobiostimulation for various medical applications	-	Europa	36/100
4th	Eyful 2019, Montreal (Canada), Funding Raised	Developer of eyeglasses for people affected by macular degeneration	-	-	22/100
5th	Novavido 2021, Bologna (Italy), Funding Raised	Developer of a medical device for retinitis pigmentosa and macular degeneration	-	UTOPIA	20/100
6th	Alpha Ret Fremont (United States), Public	Developer of ophthalmic laser therapy designed to slow AMD progression	-	-	20/100
7th	Nova Oculus Medical 2023, Palm Desert (United States), Seed	Developer of a therapeutic medical device for age-related macular degeneration	$22.5K	-	16/100
8th	Valeda 2013, Poulsbo (United States), Unfunded	Developer of light delivery system intended to improve visual acuity	-	-	16/100
9th	Idea-Amd Germany, Unfunded	Developer of diagnostic and assistive technology for macular degeneration patients	-	-	16/100